companies that sell tirzepatide Eli Lilly's Popular Weight Loss Drug, Zepbound, Is Getting a Price Cut Drugmakers Are Ditching Middlemen to

Reported Efficacy in Published Trial Data Across pivotal trials, mean weight reduction has scaled with receptor coverage in the published readouts [1][9]

doi: 10.1111/j.1365-2265.1995.tb01861.x

The recommended starting dose is 2.5mg per week for the first four weeks to minimize gastrointestinal side effects

Tirzepatide is approved by the US Food and Drug Administration (FDA) to reduce weight in adults with: Obesity Overweight plus at least one weight-related condition, like type 2 diabetes, high blood pressure, or high cholesterol Zepbound comes in a single-dose self-injectable pen that goes under the skin of your belly, thigh, or upper arm